DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Adams D, Gonzalez-Duarte A, O'Riordan WD. et al.
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis.
N Engl J Med 2018;
379 (01) 11-21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.